[Surgical therapy of liposarcoma].
The clinical course of 17 patients with liposarcoma was followed from 6 months to 20 years. Local recurrence was seen in 11 patients, metastases in 3. Survival was 1 year in one case up to 18 years in another. There was a close correlation of survival and histological findings. There was also a distinct influence of primary surgical therapy on local recurrence rate. In our opinion, the extent of excision of the primary tumor is most important in the treatment of liposarcoma.
D000328:Adult; D000368:Aged; D001132:Arm; D003131:Combined Modality Therapy; D005260:Female; D006119:Groin; D006801:Humans; D007866:Leg; D008080:Liposarcoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000601:surgery; D009367:Neoplasm Staging; D011182:Postoperative Care; D012186:Retroperitoneal Neoplasms / Q000401:mortality / Q000601:surgery
Zur chirurgischen Therapie des Liposarkoms.